CALCA and migraine disorder: However, whether CGRP and its receptors are viable therapeutic targets in migraine patients with vestibular symptoms is uncertain, and whether CGRP antibodies and CGRP1 receptor antagonists can alleviate vestibular symptoms in migraine patients requires further investigation.